Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
, 4, 1-6

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report

Affiliations
Case Reports

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report

Anthony P Conley et al. J Glob Oncol.

Figures

Fig 1
Fig 1
Imaging assessment of ipilimumab plus nivolumab antitumor activity.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Portera CA, Jr, Ho V, Patel SR, et al. : Alveolar soft part sarcoma: Clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 91:585-591, 2001 - PubMed
    1. Jaber OI, Kirby PA: Alveolar soft part sarcoma. Arch Pathol Lab Med 139:1459-1462, 2015 - PubMed
    1. Herzog CE: Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol 27:215-218, 2005 - PubMed
    1. Kummar S, Allen D, Monks A, et al. : Cediranib for metastatic alveolar soft part sarcoma. J Clin Oncol 31:2296-2302, 2013 - PMC - PubMed
    1. Stacchiotti S, Negri T, Zaffaroni N, et al. : Sunitinib in advanced alveolar soft part sarcoma: Evidence of a direct antitumor effect. Ann Oncol 22:1682-1690, 2011 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback